Epigallocatechin‐3‐Gallate Encapsulated SNEDDS: A Novel Approach for Neuroprotection in Alzheimer’s Disease

EGCG-loaded SNEDDS served as a therapeutic approach in the management of AD. Therefore, our study suggests a potential neuroprotective strategy of EGCG-loaded SNEDDS with its beneficial effects of AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_102527
Primary Topic
Berberine and alkaloids research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigallocatechin‐3‐Gallate Encapsulated SNEDDS: A Novel Approach for Neuroprotection in Alzheimer’s Disease

B. P. Pal, Bushra Bashir, Sukriti Vishwas, Sambita Panda et al.
Alzheimer s & Dementia
Berberine and alkaloids research
article

Epigallocatechin‐3‐Gallate Encapsulated SNEDDS: A Novel Approach for Neuroprotection in Alzheimer’s Disease

B. P. Pal, Bushra Bashir, Sukriti Vishwas, Sambita Panda, Sachin Kumar Singh
article en

Abstract

EGCG-loaded SNEDDS served as a therapeutic approach in the management of AD. Therefore, our study suggests a potential neuroprotective strategy of EGCG-loaded SNEDDS with its beneficial effects of AD.

Alzheimer s & DementiaVol. 21(S5)
Lovely Professional University (IN)
Good health and well-being
Openalex Percentile: Top 30%
Berberine and alkaloids research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.